soul trial oral semaglutide cardiovascular outcomes results 2025 nejm SELECT soul trial oral semaglutide cardiovascular

Losing weight with GLP-1 medications might bring balance to hormones and ease estrogen-related issues like mood swings, bloating, or irregular periods

TNF- inhibitors such as Infliximab and Etanercept did not show benefits in chronic heart failure due to the worsening of the clinical status and some serious adverse effects, such as upper respiratory tract infections [18, 19]

This can increase the risk of pulmonary aspirationa condition where food or liquid from the stomach accidentally enters the lungs during anaesthesia

For adults ages 19-50, the Adequate Intake (AI) is approximately 25 grams daily for women and 38 grams daily for men